Viktoria Blumenberg

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 13

Top Topics

Structural Basis

Acute Lymphoblastic Leukemia

Top Venues

Nature medicine

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Marion Subklewe, David M Cordas Dos Santos, Nathan H Parker, Veit L Bücklein, Michael Winkelmann, Khushali S Jhaveri, Lian Liu, Paul Trinkner, Sophie Günther, Philipp Karschnia, Viktoria Blumenberg, Christian Schmidt, Wolfgang Gerhard Kunz, Michael von Bergwelt-Baildon, Michael D Jain, Sebastian Theurich, Marion Subklewe
Influence of adipose tissue distribution, sarcopenia, and nutritional status on clinical outcomes after CD19 CAR T-cell therapy. Cancer immunology research (2023)
Christoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, Viktoria Blumenberg, Maria-Luisa Schubert, Uria Mor, Matthias A Fante, Sabine Schmidt, Eiko Hayase, Tomo Hayase, Roman Rohrbach, Chia-Chi Chang, Lauren McDaniel, Ivonne Flores, Rogier Gaiser, Matthias Edinger, Daniel Wolff, Martin Heidenreich, Paolo Strati, Ranjit Nair, Dai Chihara, Luis E Fayad, Sairah Ahmed, Swaminathan P Iyer, Raphael E Steiner, Preetesh Jain, Loretta J Nastoupil, Jason R Westin, Reetakshi Arora, Michael L Wang, Joel Turner, Meghan Menges, Melanie Hidalgo-Vargas, Kayla Reid, Peter Dreger, Anita Schmitt, Carsten Muller-Tidow, Frederick L Locke, Marco L Davila, Richard E Champlin, Christopher R Flowers, Elizabeth J Shpall, Hendrik Poeck, Sattva S Neelapu, Michael Schmitt, Marion Subklewe, Michael D Jain, Robert R Jenq, Eran Elinav
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy. Nature medicine (2023)
Gloria Iacoboni, Víctor Navarro, Ana África Martín-López, Marion Subklewe, Mi Kwon, Katarzyna Aleksandra Jalowiec, Paula Amat, Juan Luis Reguera-Ortega, Laura Gallur, Viktoria Blumenberg, Sara Gutiérrez-Herrero, Claire Roddie, Ana Benzaquén, Javier Delgado-Serrano, Mario Andrés Sánchez-Salinas, Rebeca Bailén, Cecilia Carpio, Lucia López-Corral, Rafael Hernani, Mariana Bastos-Oreiro, Maeve A O'Reilly, Lourdes Martín-Martín, Marion Subklewe, Pere Barba
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Marion Subklewe, Ariel Perez, Gloria Iacoboni, Viktoria Blumenberg, Veit L Bücklein, Simon Völkl, Olaf Penack, Omar Albanyan, Sophia Stock, Fabian Müller, Philipp Karschnia, Agnese Petrera, Kayla M Reid, Rawan G Faramand, Marco L Davila, Karnav Modi, Erin A Dean, Christina A Bachmeier, Michael von Bergwelt-Baildon, Frederick L Locke, Wolfgang Andreas Bethge, Lars Bullinger, Andreas Mackensen, Pere Barba, Michael D Jain, Marion Subklewe
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion. Science advances 9 (38) (2023)
Michael Winkelmann, Viktoria Blumenberg, Marion Subklewe, Christina Quell, Veit Bücklein, Maria Ingenerf, Marcus Unterrainer, Christian Schmidt, Franziska J Dekorsy, Peter Bartenstein, Jens Ricke, Michael von Bergwelt-Baildon, Marion Subklewe, Wolfgang Gerhard Kunz
Modification of Lugano criteria by pre-infusion tumor kinetics improves early survival prediction for patients with lymphoma under chimeric antigen receptor T-cell therapy. Journal for immunotherapy of cancer 11 (10) (2023)
Viktoria Blumenberg, Busch Galina, Stephan Baumann, Regina Jitschin, Gloria Iacoboni, Eva Hoster, Laura Gallur, Josu Iraola-Truchuelo, Michael Winkelmann, Konstantin Hellwig, Christian Schmidt, Lisa Frölich, Benjamin Tast, Friederike Hildebrand, Kai Rejeski, Franziska J Dekorsy, Christian Schmidkonz, Tobias Bäuerle, Wolfgang Gerhard Kunz, Dimitrios Mougiakakos, Fabian Müller, Michael von Bergwelt-Baildon, Pere Barba, Veit L Bücklein, Andreas Mackensen, Simon Völkl, Marion Subklewe
Early quantification of anti-CD19 CAR T-cells by flow cytometry predicts response in R/R DLBCL. Blood advances (2023)
Marion Subklewe, Zhijie Wu, Viktoria Blumenberg, Wolfgang Gerhard Kunz, Susanna Müller, Sachiko Kajigaya, Shouguo Gao, Veit L Bücklein, Lisa Frölich, Christian Schmidt, Michael von Bergwelt-Baildon, Xingmin Feng, Neal S Young, Marion Subklewe
Oligoclonal T-cell expansion in a patient with bone marrow failure after CD19 CAR-T therapy for Richter-transformed DLBCL. Blood 140 (20) (2022)
Marion Subklewe, Andreas Burchert, Gloria Iacoboni, Pierre Sesques, Lars Fransecky, Veit L Bücklein, Corinna Trenker, Rafael Hernani, Ralph Naumann, Jonas A Schäfer, Viktoria Blumenberg, Christian Schmidt, Kristina Sohlbach, Michael von Bergwelt-Baildon, Emmanuel Bachy, Pere Barba
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy. Blood advances 6 (16) (2022)
Philipp Karschnia, Kai Rejeski, Michael Winkelmann, Florian Schöberl, Veit L Bücklein, Viktoria Blumenberg, Christian Schmidt, Jens Blobner, Michael von Bergwelt-Baildon, Joerg-Christian Tonn, Wolfgang G Kunz, Marion Subklewe, Louisa von Baumgarten
Toxicities and Response Rates of Secondary CNS Lymphoma After Adoptive Immunotherapy With CD19-Directed Chimeric Antigen Receptor T Cells. Neurology 98 (21) (2022)
Florian Schoeberl, Steffen Tiedt, Anita Schmitt, Viktoria Blumenberg, Philipp Karschnia, Vanessa Granja Burbano, Veit L Bücklein, Marion Subklewe, Christian Schmidt, Galina Busch, Michael von Bergwelt-Baildon, Jörg-Christian Tonn, Michael Schmitt, Marion Subklewe, Louisa von Baumgarten
Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment. Blood advances 6 (10) (2022)
Hannah Reimann, Anita N Kremer, Viktoria Blumenberg, Katja Gabriele Schmidt, Michael Aigner, Benedikt Jacobs, Nina Eisenhauer, Alina Kämpf, Wolf Roesler, Soraya Kharboutli, Dimitrios Mougiakakos, Vanessa Lang, Christopher Lischer, Pascal Irrgang, Moritz Leppkes, Julio Vera Gonzalez, Gerhard Krönke, Andreas E Kremer, Matthias Tenbusch, Heiko Bruns, Thomas Harrer, Fabian Müller, Georg Schett, Andreas Mackensen, Marion Subklewe, Simon Völkl
Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR-T cell therapy. Blood advances (2022)
Stefanie Lesch, Viktoria Blumenberg, Stefan Stoiber, Adrian Gottschlich, Justyna Ogonek, Bruno Loureiro Cadilha, Zahra Dantes, Felicitas Rataj, Klara Dorman, Johannes Lutz, Clara H Karches, Constanze Heise, Mathias Kurzay, Benjamin M Larimer, Simon Grassmann, Moritz Rapp, Alessia Nottebrock, Stephan Kruger, Nicholas Tokarew, Philipp Metzger, Christine Hoerth, Mohamed-Reda Benmebarek, Dario Dhoqina, Ruth Grünmeier, Matthias Seifert, Arman Oener, Öykü Umut, Sandy Joaquina, Lene Vimeux, Thi Tran, Thomas Hank, Taisuke Baba, Duc Huynh, Remco T A Megens, Klaus-Peter Janssen, Martin Jastroch, Daniel Lamp, Svenja Ruehland, Mauro Di Pilato, Jasper N Pruessmann, Moritz Thomas, Carsten Marr, Steffen Ormanns, Anna Reischer, Michael Hristov, Eric Tartour, Emmanuel Donnadieu, Simon Rothenfußer, Peter Duewell, Lars M Koenig, Max Schnurr, Marion Subklewe, Andrew S Liss, Niels Halama, Maximilian Reichert, Thorsten R Mempel, Stefan Endres, Sebastian Kobold
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours. Nature biomedical engineering 5 (11) (2021)
Kai Rejeski, Ariel Perez Perez, Pierre Sesques, Eva Hoster, Carolina Susanna Berger, Liv Jentzsch, Dimitrios Mougiakakos, Lisa Frölich, Josephine Ackermann, Veit L Bücklein, Viktoria Blumenberg, Christian Schmidt, Laurent Jallades, Boris Fehse, Christoph Faul, Philipp Karschnia, Oliver Weigert, Martin Dreyling, Frederick L Locke, Michael von Bergwelt-Baildon, Andreas Mackensen, Wolfgang Andreas Bethge, Francis Ayuk, Emmanuel Bachy, Gilles Andre Salles, Michael D Jain, Marion Subklewe
CAR-HEMATOTOX: A model for CAR T-cell related hematological toxicity in relapsed/refractory large B-cell lymphoma. Blood (2021)